
|Videos|May 3, 2022
Pharmaceutical CEO Leadership: Real-World Evidence
Among the topics discussed at Pharm Exec’s recent RWE roundtable are how the pandemic has served to validate the use of RWE/RWD; the most important features of a real-world data set; and key considerations when selecting an RWD partner.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
U.S. House Committee Investigating Drugmakers Involved in China Drug Trials: Report
2
Preparing for the July 31 Pharma Tariff Deadline
3
FDA Announces Seven Participants to PreCheck Pilot Program
4
Wegovy Now Available to Eligible Medicare Beneficiaries Through Medicare GLP-1 Bridge
5




